Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06735651 · ClinicalTrials.gov registry record · NA

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

A NA study of Overweight and Inflammation, sponsored by Georgia State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06735651: Recruiting NA study of Overweight and Inflammation, sponsored by Georgia State University.

NCT06735651 is a NA study of Overweight and Inflammation that is actively recruiting participants, run by Georgia State University. The registered enrollment target is 30 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06735651, a NA study of Overweight and Inflammation, is actively recruiting participants, sponsored by Georgia State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, and gut microbiota composition in adult women with prediabetes.

Primary Outcome

Measurement of fasting blood glucose

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Wild Blueberry

Study Locations (1)

Georgia

  • Georgia State University - Atlanta

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-09-20
Est. Completion 2026-06-01
Phase NA
Georgia State University

45 total trials

What NCT06735651 shows while recruiting

NCT06735651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower).

The record links to 10 conditions, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06735651 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06735651 about?

NCT06735651 is a clinical study titled "Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes". The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, and gut microbiota composition in adult women with prediabetes.

What is the current status of trial NCT06735651?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-20. Estimated completion is 2026-06-01.

What conditions does trial NCT06735651 study?

This clinical trial studies the following conditions: Overweight, Inflammation, Oxidative Stress, Cognition, Arterial Stiffness.

What interventions are being tested in trial NCT06735651?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Wild Blueberry (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06735651?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06735651 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06735651's enrollment target sits among peer trials

30 168th of 197 higher than 28 of 197 other Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06735651, the US trial registry maintained by the National Library of Medicine. NCT06735651 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.